Skip to main content
LFCR
NASDAQ Life Sciences

Legion Partners Locks Up 17.3% Stake in Support of Webster Equity Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.62
Mkt Cap
$246.802M
52W Low
$3.625
52W High
$8.98
52W Position info
83% above low
Off High info
26% below high
Rel. Volume info
19× avg
Market data snapshot near publication time

LFCR sits 83% above its 52-week low of $3.625 on elevated volume (19× avg).

Summary

Legion Partners, holding 17.3% of Lifecore, signed a voting agreement backing the Webster Equity Partners acquisition at $6.28 per share plus CVRs, locking up its shares and committing votes in favor of the deal.


Key Events · M&A and Partnerships · LFCR

  • Voting Agreement Signed

    On September 27, 2026, Legion Partners entered a voting and support agreement, committing its 6,991,919 shares (17.3%) to vote in favor of the Webster Equity Partners merger and against any competing acquisition proposal.

  • Merger Consideration

    Common stockholders receive $6.28 per share in cash plus one contingent value right (CVR) per share. Series A Preferred Stock converts to cash equal to its Conversion Amount plus CVRs.

  • Transfer Restrictions

    Legion Partners agreed not to transfer any Covered Shares until the earlier of the stockholder vote, merger effective time, termination of the merger agreement, or a Company Adverse Change Recommendation.

  • Activist Alignment

    Legion Partners had previously demanded redemption of its Series A Preferred Stock, creating liquidity pressure. The voting agreement removes this overhang and aligns the activist with the buyer.


Analysis · LFCR · Life Sciences

A binding voting agreement now commits activist investor Legion Partners to support the $6.28 per share cash-plus-CVR acquisition by Webster Equity Partners. The agreement bars Legion from transferring its 6.99 million shares and requires votes in favor of the merger and against any competing proposal. This removes a key obstacle to deal completion, as Legion had previously demanded redemption of its Series A Preferred Stock, creating liquidity pressure. The lock-up signals alignment between the activist and the buyer, increasing the probability the merger closes.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LFCR was trading at $6.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $246.8M. The 52-week trading range was $3.63 to $8.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFCR - Latest Insights

LFCR
Nov 04, 2026, 7:13 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.38
Real-time Price: $6.40 info
Change: +$0.0196 (+0.31%) info
Market Cap: $242.597M info
LFCR
Oct 30, 2026, 5:26 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $6.40
Real-time Price: $6.40 info
Change: $0 (0%) info
Market Cap: $242.597M info
LFCR
Sep 29, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.52
Real-time Price: $6.40 info
Change: -$0.120 (-2%) info
Market Cap: $242.597M info
LFCR
Sep 28, 2026, 8:56 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $6.40 info
Change: +$2.10 (+49%) info
Market Cap: $242.597M info
LFCR
Sep 28, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $6.40 info
Change: +$2.10 (+49%) info
Market Cap: $242.597M info